✦ LIBER ✦

Novel aspects of osteoclast activation and osteoblast inhibition in myeloma bone disease

✍ Scribed by Ulrike Heider; Lorenz C. Hofbauer; Ivana Zavrski; Martin Kaiser; Christian Jakob; Orhan Sezer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biochemical markers of bone metabolism r

✍ N. Abildgaard; H. Glerup; J. Rungby; K. Bendix-Hansen; M. Kassem; K. Brixen; L. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB

Novel bromomelatonin derivatives suppres

✍ Nobuo Suzuki; Masanori Somei; Kei-Ichiro Kitamura; Russel J. Reiter; Atsuhiko Ha 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 341 KB

Bortezomib directly inhibits osteoclast

✍ Evangelos Terpos 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Long-term oral pamidronate treatment inh

✍ N. Abildgaard; J. Rungby; H. Glerup; K. Brixen; M. Kassem; H. Brincker; L. Heick 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 714 KB

Relation of Osteoclast Activating Factor

✍ Brian G. M. Durie; Sydney E. Salmon; Gregory R. Mundy 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 568 KB

A novel role for CCL3 (MIP-1α) in myelom

✍ Vallet, S; Pozzi, S; Patel, K; Vaghela, N; Fulciniti, M T; Veiby, P; Hideshima, 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 529 KB